Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016 (2016), Article ID 3082820, 8 pages
http://dx.doi.org/10.1155/2016/3082820
Research Article

Smoking Functions as a Negative Regulator of IGF1 and Impairs Adipokine Network in Patients with Rheumatoid Arthritis

Department of Rheumatology and Inflammation Research, Sahlgrenska Medical Academy, Gothenburg University, 40583 Gothenburg, Sweden

Received 14 September 2015; Revised 3 February 2016; Accepted 7 February 2016

Academic Editor: Oreste Gualillo

Copyright © 2016 Malin C. Erlandsson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. US Department of Health and Human Services, The Health Consequences of Smoking—50 Years of Progress. A Report of the Surgeon General, 2014, http://www.surgeongeneral.gov/library/reports/50-years-of-progress/full-report.pdf.
  2. J.-F. Boyer, P.-A. Gourraud, A. Cantagrel, J.-L. Davignon, and A. Constantin, “Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis,” Joint Bone Spine, vol. 78, no. 2, pp. 179–183, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Klareskog, P. Stolt, K. Lundberg et al., “A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination,” Arthritis & Rheumatism, vol. 54, no. 1, pp. 38–46, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Sugiyama, K. Nishimura, K. Tamaki et al., “Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies,” Annals of the Rheumatic Diseases, vol. 69, no. 1, pp. 70–81, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Di Giuseppe, A. Discacciati, N. Orsini, and A. Wolk, “Cigarette smoking and risk of rheumatoid arthritis: a dose-response meta-analysis,” Arthritis Research & Therapy, vol. 16, no. 2, article R61, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Sokka, M. L. Hetland, H. Mäkinen et al., “Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries,” Arthritis and Rheumatism, vol. 58, no. 9, pp. 2642–2651, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Saevarsdottir, S. Wedren, M. Seddighzadeh et al., “Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the epidemiological investigation of rheumatoid arthritis and the Swedish Rheumatology Register cohorts,” Arthritis & Rheumatism, vol. 63, no. 1, pp. 26–36, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. J. M. W. Hazes, B. A. C. Dijkmans, J. P. Vandenbroucke, R. R. P. De Vries, and A. Cats, “Lifestyle and the risk of rheumatoid arthritis: cigarette smoking and alcohol consumption,” Annals of the Rheumatic Diseases, vol. 49, no. 12, pp. 980–982, 1990. View at Publisher · View at Google Scholar · View at Scopus
  9. V. Vesperini, C. Lukas, B. Fautrel, X. Le Loet, N. Rincheval, and B. Combe, “Association of tobacco exposure and reduction of radiographic progression in early rheumatoid arthritis: results from a French multicenter cohort,” Arthritis Care & Research, vol. 65, no. 12, pp. 1899–1906, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Finckh, S. Dehler, K. H. Costenbader, and C. Gabay, “Cigarette smoking and radiographic progression in rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 66, no. 8, pp. 1066–1071, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Jiang, L. Alfredsson, L. Klareskog, and C. Bengtsson, “Smokeless tobacco (moist snuff) use and the risk of developing rheumatoid arthritis: results from a case-control study,” Arthritis Care & Research, vol. 66, no. 10, pp. 1582–1586, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Landin-Wilhelmsen, L. Wilhelmsen, G. Lappas et al., “Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin,” Clinical Endocrinology, vol. 41, no. 3, pp. 351–357, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. J. M. Faupel-Badger, D. Berrigan, R. Ballard-Barbash, and N. Potischman, “Anthropometric correlates of insulin-like growth factor 1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels by race/ethnicity and gender,” Annals of Epidemiology, vol. 19, no. 12, pp. 841–849, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. J. E. Puche and I. Castilla-Cortazar, “Human conditions of insulin-like growth factor-I (IGF-I) deficiency,” Journal of Translational Medicine, vol. 10, no. 1, article 224, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. Q. Bao, J. Pan, H. Qi et al., “Aging and age-related diseases—from endocrine therapy to target therapy,” Molecular and Cellular Endocrinology, vol. 394, no. 1-2, pp. 115–118, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. M. H. Sheng, K. H. Lau, and D. J. Baylink, “Role of osteocyte-derived insulin-like growth factor i in developmental growth, modeling, remodeling, and regeneration of the bone,” Journal of Bone Metabolism, vol. 21, no. 1, pp. 41–54, 2014. View at Publisher · View at Google Scholar
  17. M. S. Sandhu, A. H. Heald, J. M. Gibson, J. K. Cruickshank, D. B. Dunger, and N. J. Wareham, “Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study,” The Lancet, vol. 359, no. 9319, pp. 1740–1745, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Frystyk, T. Ledet, N. Møller, A. Flyvbjerg, and H. Ørskov, “Cardiovascular disease and insulin-like growth factor I,” Circulation, vol. 106, no. 8, pp. 893–895, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Matsumoto and T. Tsurumoto, “Inappropriate serum levels of IGF-I and IGFBP-3 in patients with rheumatoid arthritis,” Rheumatology, vol. 41, no. 3, pp. 352–353, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. E. A. Bostrom, M. Svensson, S. Andersson et al., “Resistin and insulin/insulin-like growth factor signaling in rheumatoid arthritis,” Arthritis & Rheumatism, vol. 63, no. 10, pp. 2894–2904, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Lemmey, P. Maddison, A. Breslin et al., “Association between insulin-like growth factor status and physical activity levels in rheumatoid arthritis,” The Journal of Rheumatology, vol. 28, no. 1, pp. 29–34, 2001. View at Google Scholar · View at Scopus
  22. É. Toussirot, N. U. Nguyen, G. Dumoulin, F. Aubin, J.-P. Cédoz, and D. Wendling, “Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis,” Rheumatology, vol. 44, no. 1, pp. 120–125, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. J. C. O’Connor, R. H. McCusker, K. Strle, R. W. Johnson, R. Dantzer, and K. W. Kelley, “Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology,” Cellular Immunology, vol. 252, no. 1-2, pp. 91–110, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. N. K. Saxena, L. Taliaferro-Smith, B. B. Knight et al., “Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor,” Cancer Research, vol. 68, no. 23, pp. 9712–9722, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Jacques, M. Holzenberger, Z. Mladenovic et al., “Proinflammatory actions of visfatin/nicotinamide phosphoribosyltransferase (Nampt) involve regulation of insulin signaling pathway and Nampt enzymatic activity,” The Journal of Biological Chemistry, vol. 287, no. 18, pp. 15100–15108, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. J. T. Giles, D. M. van der Heijde, and J. M. Bathon, “Association of circulating adiponectin levels with progression of radiographic joint destruction in rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 70, no. 9, pp. 1562–1568, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. I. R. Klein-Wieringa, M. P. M. van der Linden, R. Knevel et al., “Baseline serum adipokine levels predict radiographic progression in early rheumatoid arthritis,” Arthritis and Rheumatism, vol. 63, no. 9, pp. 2567–2574, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Klaasen, M. M. J. Herenius, C. A. Wijbrandts et al., “Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 71, no. 9, pp. 1510–1516, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. H. Rho, J. Solus, T. Sokka et al., “Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis,” Arthritis & Rheumatism, vol. 60, no. 7, pp. 1906–1914, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. Y.-J. Park, C.-S. Cho, P. Emery, and W.-U. Kim, “LDL cholesterolemia as a novel risk factor for radiographic progression of rheumatoid arthritis: a single-center prospective study,” PLoS ONE, vol. 8, no. 7, Article ID e68975, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. M. F. Bakker, G. Cavet, J. W. G. Jacobs et al., “Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study,” Annals of the Rheumatic Diseases, vol. 71, no. 10, pp. 1692–1697, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Hirata, L. Dirven, Y. Shen et al., “A multi-biomarker score measures rheumatoid arthritis disease activity in the best study,” Rheumatology, vol. 52, no. 7, pp. 1202–1207, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Yusuf, A. Ioan-Facsinay, J. Bijsterbosch et al., “Association between leptin, adiponectin and resistin and long-term progression of hand osteoarthritis,” Annals of the Rheumatic Diseases, vol. 70, no. 7, pp. 1282–1284, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Popa, M. G. Netea, T. R. D. S. Radstake, P. L. Van Riel, P. Barrera, and J. W. M. Van Der Meer, “Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 64, no. 8, pp. 1195–1198, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. C.-Y. Chen, C.-Y. Tsai, P.-C. Lee, and S.-D. Lee, “Long-term etanercept therapy favors weight gain and ameliorates cachexia in rheumatoid arthritis patients: roles of gut hormones and leptin,” Current Pharmaceutical Design, vol. 19, no. 10, pp. 1956–1964, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Bernotiene, G. Palmer, D. Talabot-Ayer, I. Szalay-Quinodoz, M. L. Aubert, and C. Gabay, “Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice,” Arthritis Research & Therapy, vol. 6, no. 3, pp. R256–R263, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. O. H. Hultgren and A. Tarkowski, “Leptin in septic arthritis: decreased levels during infection and amelioration of disease activity upon its adminstration,” Arthritis Research, vol. 3, no. 6, pp. 389–394, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. R. H. Unger, “Hyperleptinemia: protecting the heart from lipid overload,” Hypertension, vol. 45, no. 6, pp. 1031–1034, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. C. C. T. Smith, M. M. Mocanu, S. M. Davidson, A. M. Wynne, J. C. Simpkin, and D. M. Yellon, “Leptin, the obesity-associated hormone, exhibits direct cardioprotective effects,” British Journal of Pharmacology, vol. 149, no. 1, pp. 5–13, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Morita, K. Maeda, T. Kondo et al., “Impact of adiponectin and leptin on long-term adverse events in Japanese patients with acute myocardial infarction. Results from the Nagoya Acute Myocardial Infarction Study (NAMIS),” Circulation Journal, vol. 77, no. 11, pp. 2778–2785, 2013. View at Google Scholar
  41. R. L. Bracho-Riquelme, V. Loera-Castañeda, A. Torres-Valenzuela, G. A. Loera-Castañeda, and J. P. Sánchez-Ramírez, “Leptin and leptin receptor polymorphisms are associated with poor outcome (death) in patients with non-appendicular secondary peritonitis,” Critical Care, vol. 15, no. 5, article R227, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. C. K. Welt, J. L. Chan, J. Bullen et al., “Recombinant human leptin in women with hypothalamic amenorrhea,” The New England Journal of Medicine, vol. 351, no. 10, pp. 987–997, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. S. H. Chou, J. P. Chamberland, X. Liu et al., “Leptin is an effective treatment for hypothalamic amenorrhea,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 16, pp. 6585–6590, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. S. M. Bartell, S. Rayalam, S. Ambati et al., “Central (ICV) leptin injection increases bone formation, bone mineral density, muscle mass, serum IGF-1, and the expression of osteogenic genes in leptin-deficient ob/ob mice,” Journal of Bone and Mineral Research, vol. 26, no. 8, pp. 1710–1720, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. G. M. Lord, G. Matarese, J. K. Howard, R. J. Baker, S. R. Bloom, and R. I. Lechler, “Leptin modulates the T-cell immune response and reverses starvation- induced immunosuppression,” Nature, vol. 394, no. 6696, pp. 897–901, 1998. View at Publisher · View at Google Scholar · View at Scopus
  46. I. S. Farooqi, G. Matarese, G. M. Lord et al., “Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency,” The Journal of Clinical Investigation, vol. 110, no. 8, pp. 1093–1103, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Procaccini, V. De Rosa, M. Galgani et al., “Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4+ effector T cell responses,” The Journal of Immunology, vol. 189, no. 6, pp. 2941–2953, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. N. Busso, A. So, V. Chobaz-Péclat et al., “Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis,” Journal of Immunology, vol. 168, no. 2, pp. 875–882, 2002. View at Publisher · View at Google Scholar · View at Scopus
  49. L. Otvos Jr., W.-H. Shao, A. S. Vanniasinghe et al., “Toward understanding the role of leptin and leptin receptor antagonism in preclinical models of rheumatoid arthritis,” Peptides, vol. 32, no. 8, pp. 1567–1574, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Deng, Y. Liu, M. Yang et al., “Leptin exacerbates collagen-induced arthritis via enhancement of Th17 cell response,” Arthritis & Rheumatism, vol. 64, no. 11, pp. 3564–3573, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Bokarewa, D. Bokarew, O. Hultgren, and A. Tarkowski, “Leptin consumption in the inflamed joints of patients with rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 62, no. 10, pp. 952–956, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. S. M. Olama, M. K. Senna, and M. Elarman, “Synovial/serum leptin ratio in rheumatoid arthritis: the association with activity and erosion,” Rheumatology International, vol. 32, no. 3, pp. 683–690, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. J. T. Giles, M. Allison, C. O. Bingham III, W. M. Scott Jr., and J. M. Bathon, “Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis,” Arthritis Care and Research, vol. 61, no. 9, pp. 1248–1256, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Meyer, J. Sellam, S. Fellahi et al., “Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort,” Arthritis Research & Therapy, vol. 15, no. 6, article R210, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. V. Tillmann, L. Patel, M. S. Gill et al., “Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth,” Clinical Endocrinology, vol. 53, no. 3, pp. 329–336, 2000. View at Google Scholar
  56. A. Ciresi, M. C. Amato, A. Criscimanna et al., “Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency,” European Journal of Endocrinology/European Federation of Endocrine Societies, vol. 156, no. 3, pp. 353–360, 2007. View at Publisher · View at Google Scholar
  57. P.-H. Su, J.-Y. Chen, J.-S. Yu, S.-J. Chen, and S.-F. Yang, “Leptin expression and leptin receptor gene polymorphisms in growth hormone deficiency patients,” Human Genetics, vol. 129, no. 4, pp. 455–462, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Connor Gorber, S. Schofield-Hurwitz, J. Hardt, G. Levasseur, and M. Tremblay, “The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status,” Nicotine & Tobacco Research, vol. 11, no. 1, pp. 12–24, 2009. View at Publisher · View at Google Scholar · View at Scopus